Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    24024757 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Efficacy and Safety of Sodium Alginate Oral Suspension to Treat Non-erosive Gastro-esophageal Reflux Disease
Conditions: Gastroesophageal Reflux Disease;   Heartburn
Interventions: Drug: Sodium alginate;   Drug: Omeprazole

Indicates status has not been verified in more than two years